“…Cholesterol 25-hydroxylase (CH25H) encodes an ER-associated enzyme that catalyzes the oxidation of cholesterol to 25HC (Blanc et al, 2013;Hotter et al, 2013). Recent reports have revealed that CH25H inhibits many enveloped viruses, including vesicular stomatitis virus (VSV) (Liu et al, 2013), human immunodeficiency virus (HIV) (Moog et al, 1998), hepatitis C virus (HCV) (Anggakusuma et al, 2015), Ebola virus (EBOV) (Liu et al, 2013), porcine reproductive and respiratory syndrome virus (PRRSV) (Song et al, 2017), pseudorabies virus (PRV) and Zika virus (Li et al, 2017a), as well as some non-enveloped viruses, such as human rotavirus and human rhinovirus (Fessler, 2016). However, the antiviral effects and mechanisms of CH25H and 25HC on PEDV are still unclear.…”